Trials / Recruiting
RecruitingNCT06640218
The Effect of Eddy Sonic Versus AF Max Activation of Bio-ceramic Sealer on Post-operative Pain in Teeth with Symptomatic Irreversible Pulpitis with Apical Periodontitis
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 30 (estimated)
- Sponsor
- Future University in Egypt · Academic / Other
- Sex
- All
- Age
- 18 Years – 40 Years
- Healthy volunteers
- Accepted
Summary
The aim of endodontic therapy for an inflamed tooth is to eliminate the source of inflammation. Relieving pain depends on the effectiveness of root canal therapy.3 Postoperative pain in endodontic treatments, affecting 3-58% of patients, is often caused by peri-radicular tissue injuries. Understanding these factors helps professionals select methods and supplies to minimize discomfort. 30 patients will be divided into 3 groups according to the method of activation (10 par ticipants/each). participants will be recruited from the postgrad clinic of the endodontic department faculty of oral and dental medicine, Future University in Egypt Patients with mature mandibular first permanent molar with irreversible pulpitis with apical periodontitis Intervention 1: bio-ceramic sealer activation with Eddy sonic Intervention 2: bio-ceramic sealer activation with AF max Control/Comparator: bio-ceramic sealer without activation The study aims to evaluate the effect of Eddy Sonic and AF max activation of bio-ceramic sealer on postoperative pain in mandibular first molars with symptomatic irreversible pulpitis with apical periodontitis
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | sealer activation with Eddy sonic and AF max | activation of sealer after cleaning and shaping, before the obturation |
| OTHER | without AF max or Eddy sonic sealer activation | sealer without activation |
Timeline
- Start date
- 2024-11-01
- Primary completion
- 2025-11-01
- Completion
- 2026-04-01
- First posted
- 2024-10-15
- Last updated
- 2024-10-15
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT06640218. Inclusion in this directory is not an endorsement.